Found: 40
Select item for more details and to access through your institution.
Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 829, doi. 10.1007/s00262-009-0807-3
- By:
- Publication type:
- Article
PankoMab: a potent new generation anti-tumour MUC1 antibody.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 11, p. 1337, doi. 10.1007/s00262-006-0135-9
- By:
- Publication type:
- Article
Immunomodulatory impact of interferon-alpha in combination with chemoradiation of pancreatic adenocarcinoma (CapRI).
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 11, p. 1396, doi. 10.1007/s00262-006-0140-z
- By:
- Publication type:
- Article
Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivo.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 1, p. 31, doi. 10.1007/s00262-005-0690-5
- By:
- Publication type:
- Article
Dendritic cells reduce number and function of CD4<sup>+</sup>CD25<sup>+</sup> cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 11, p. 1018, doi. 10.1007/s00262-004-0554-4
- By:
- Publication type:
- Article
Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 637, doi. 10.1007/s00262-002-0324-0
- By:
- Publication type:
- Article
Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 25, doi. 10.1007/s00262-001-0251-5
- By:
- Publication type:
- Article
Characterization of Primary Renal Carcinoma Cultures.
- Published in:
- Urologia Internationalis, 2007, v. 79, n. 3, p. 235, doi. 10.1159/000107956
- By:
- Publication type:
- Article
Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing γδ T cell cytotoxicity.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 10, p. 2359, doi. 10.1002/ijc.22186
- By:
- Publication type:
- Article
Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6).
- Published in:
- Patient, 2018, v. 11, n. 1, p. 131, doi. 10.1007/s40271-017-0287-z
- By:
- Publication type:
- Article
Induction of Apoptosis in B Lymphoma Cells by Activation with CD40L.
- Published in:
- Acta Haematologica, 2000, v. 103, n. 3, p. 168, doi. 10.1159/000041042
- By:
- Publication type:
- Article
Increase in the immunostimulatory effect of dendritic cells by pulsing with serum derived from pancreatic and colorectal cancer patients.
- Published in:
- International Journal of Colorectal Disease, 2000, v. 15, n. 4, p. 197, doi. 10.1007/s003840000243
- By:
- Publication type:
- Article
Observational Study of Sequential Afatinib and Osimertinib in EGFR Mutation-Positive NSCLC: Patients Treated with a 40-mg Starting Dose of Afatinib.
- Published in:
- 2020
- By:
- Publication type:
- journal article
An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells.
- Published in:
- Cancer Gene Therapy, 2001, v. 8, n. 6, p. 430, doi. 10.1038/sj.cgt.7700323
- By:
- Publication type:
- Article
Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs.
- Published in:
- Cancer Gene Therapy, 2001, v. 8, n. 3, p. 211, doi. 10.1038/sj.cgt.7700292
- By:
- Publication type:
- Article
Increase in proliferation rate and normalization of TNF-α secretion by blockage of gene transfer–induced apoptosis in lymphocytes using low-dose cyclosporine A.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 11, p. 1411, doi. 10.1038/sj.cgt.7700256
- By:
- Publication type:
- Article
Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 8, p. 1145, doi. 10.1038/sj.cgt.7700209
- By:
- Publication type:
- Article
First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1569, doi. 10.1007/s00432-019-02862-x
- By:
- Publication type:
- Article
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG).
- Published in:
- Oncologist, 2022, v. 27, n. 4, p. 255, doi. 10.1093/oncolo/oyac022
- By:
- Publication type:
- Article
Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors.
- Published in:
- Oncologist, 2015, v. 20, n. 10, p. 1167, doi. 10.1634/theoncologist.2015-0073
- By:
- Publication type:
- Article
Experience With Afatinib in Patients With Non-Small Cell Lung Cancer Progressing After Clinical Benefit From Gefitinib and Erlotinib.
- Published in:
- Oncologist, 2014, v. 19, n. 10, p. 1100, doi. 10.1634/theoncologist.2014-0103
- By:
- Publication type:
- Article
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104.
- Published in:
- Acta Oncologica, 2015, v. 54, n. 7, p. 993, doi. 10.3109/0284186X.2015.1034877
- By:
- Publication type:
- Article
SAP and SLAM expression in anti‐CD3 activated lymphocytes correlates with cytotoxic activity.
- Published in:
- Immunology & Cell Biology, 2005, v. 83, n. 1, p. 33, doi. 10.1111/j.1440-1711.2005.01302.x
- By:
- Publication type:
- Article
SAP and SLAM expression in anti-CD3 activated lymphocytes correlates with cytotoxic activity.
- Published in:
- Immunology & Cell Biology, 2005, v. 83, n. 1, p. 33, doi. 10.1111/j.1440-1711.2004.01302.x
- By:
- Publication type:
- Article
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.
- Published in:
- 2014
- By:
- Publication type:
- journal article
A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2.
- Published in:
- 2009
- By:
- Publication type:
- journal article
An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2nd or higher line chemotherapy regarding clinical benefit - PANUSCO.
- Published in:
- 2009
- By:
- Publication type:
- journal article
A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Interferon Alpha-2b and 5-FU Alone or in Combination with Either External Radiation Treatment and Cisplatin (CapRI) or Radiation alone regarding Event-Free Survival -- CapRI-2.
- Published in:
- BMC Cancer, 2009, v. 9, p. 1, doi. 10.1186/1471-2407-9-160
- By:
- Publication type:
- Article
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.834704
- By:
- Publication type:
- Article
Activation of nuclear factor-κB in macrophages by mycoplasmal lipopeptides.
- Published in:
- European Journal of Immunology, 1998, v. 28, n. 12, p. 4207, doi. 10.1002/(SICI)1521-4141(199812)28:12<4207::AID-IMMU4207>3.0.CO;2-R
- By:
- Publication type:
- Article
Novel non-viral method for transfection of primary leukemia cells and cell lines.
- Published in:
- Genetic Vaccines & Therapy, 2004, v. 2, p. 1, doi. 10.1186/1479-0556-2-1
- By:
- Publication type:
- Article
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-624
- By:
- Publication type:
- Article
Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
- Published in:
- Liver International, 2006, v. 26, n. 3, p. 369, doi. 10.1111/j.1478-3231.2005.01235.x
- By:
- Publication type:
- Article
Effects of parenteral nutrition + best supportive nutritional care vs. best supportive nutritional care alone on quality of life in patients with pancreatic cancer—a secondary analysis of PANUSCO.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 7, p. 1, doi. 10.1007/s00520-024-08666-1
- By:
- Publication type:
- Article
Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series.
- Published in:
- OncoTargets & Therapy, 2024, v. 17, p. 267, doi. 10.2147/OTT.S440979
- By:
- Publication type:
- Article
Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional Studies.
- Published in:
- OncoTargets & Therapy, 2022, v. 15, p. 873, doi. 10.2147/OTT.S362535
- By:
- Publication type:
- Article
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 8575, doi. 10.2147/OTT.S160358
- By:
- Publication type:
- Article
Telomerase-specific T-cells kill pancreatic tumor cells in vitro and in vivo.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 4, p. 759, doi. 10.1002/cncr.21655
- By:
- Publication type:
- Article